Effect of cancer treatment on vascular function in patients with testicular cancer

• Conditions: Testicular cancer; MedDRA version: 14.1Level: LLTClassification code 10043362Term: Testis neoplasm malignantSystem Organ Class: 100000004864; MedDRA version: 14.1Level: LLTClassification code 10043321Term: Testicular germ cell cancer NOSSystem Organ Class: 100000004864; Therapeutic area: Diseases [C] - Cancer [C04]

• Registration Number: EUCTR2012-004450-28-FI
• Lead Sponsor: niversity of Turku

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-01-07
• Last Update Posted: 30 September 2013

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

Newly diagnosed testicular cancer
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 80
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: To study possible adverse effects of chemotherapy on endothelial function;Secondary Objective: Mechanisms of endothelial injury;Primary end point(s): Endothelial injury;Timepoint(s) of evaluation of this end point: Pre-treatment, immediately after second chemotherapy cycle and one year after completion of treatment

Secondary Outcome Measures

Name	Time	Method
Secondary end point(s): None;Timepoint(s) of evaluation of this end point: None